Advertisement

Topics

STAT Plus: Pharmalittle: India’s hard-line pharma rules hit a roadblock; Amgen goes on defense

08:33 EDT 24 Aug 2017 | STAT

India's law ministry has rejected a proposal from the Department of Pharmaceuticals that would cap prices for certain products, among other measures.

Original Article: STAT Plus: Pharmalittle: India’s hard-line pharma rules hit a roadblock; Amgen goes on defense

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Pharmalittle: India’s hard-line pharma rules hit a roadblock; Amgen goes on defense"

Advertisement
Quick Search
Advertisement
Advertisement